| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.6 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.6 |